1.30
price up icon4.00%   0.05
after-market Handel nachbörslich: 1.30
loading

Prelude Therapeutics Inc Aktie (PRLD) Neueste Nachrichten

pulisher
Oct 14, 2025

Is Prelude Therapeutics Incorporated stock supported by innovation pipelineEarnings Performance Report & Reliable Breakout Forecasts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Can Prelude Therapeutics Incorporated stock sustain free cash flow growthJuly 2025 Decliners & Breakout Confirmation Alerts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Can Prelude Therapeutics Incorporated stock maintain operating marginsEarnings Recap Report & Fast Gaining Stock Reports - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is Prelude Therapeutics Incorporated stock a defensive play in 20252025 Trading Recap & Free Daily Entry Point Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Using Bollinger Bands to evaluate Prelude Therapeutics IncorporatedCEO Change & AI Forecasted Entry/Exit Points - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How moving averages guide Prelude Therapeutics Incorporated tradingInsider Buying & Weekly Market Pulse Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Will Prelude Therapeutics Incorporated stock deliver shareholder value2025 Price Targets & High Return Stock Watch Alerts - newser.com

Oct 13, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 05:09:32 - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Can momentum traders help lift Prelude Therapeutics IncorporatedEarnings Summary Report & AI Driven Price Predictions - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Using economic indicators to assess Prelude Therapeutics Incorporated potentialFed Meeting & Safe Capital Allocation Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 02:10:25 - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Analyzing Prelude Therapeutics Incorporated with risk reward ratio charts2025 Big Picture & Free Safe Capital Growth Stock Tips - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

CDK4/6 Inhibitor Market Positioned for Remarkable Growth as Revolutionary Therapies Transform Cancer Treatment Landscape in 2024 - Barchart.com

Oct 06, 2025
pulisher
Oct 05, 2025

Full technical analysis of Prelude Therapeutics Incorporated stock2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will Prelude Therapeutics Incorporated rebound enough to break evenEarnings Risk Report & Fast Momentum Entry Tips - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Multi asset correlation models including Prelude Therapeutics IncorporatedInsider Buying & Weekly Watchlist for Consistent Profits - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will earnings trigger a reversal in Prelude Therapeutics IncorporatedPortfolio Return Summary & Verified Swing Trading Watchlists - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

What drives Prelude Therapeutics Incorporated stock priceSector-Based Investing & Double Digit Trading Ideas - earlytimes.in

Oct 02, 2025
pulisher
Sep 28, 2025

Contrasting Cardiol Therapeutics (NASDAQ:CRDL) & Prelude Therapeutics (NASDAQ:PRLD) - Defense World

Sep 28, 2025
pulisher
Sep 27, 2025

Prelude Therapeutics (NASDAQ:PRLD) versus Talphera (NASDAQ:TLPH) Financial Contrast - Defense World

Sep 27, 2025
pulisher
Sep 26, 2025

3 Promising Penny Stocks With Over $60M Market Cap - simplywall.st

Sep 26, 2025
pulisher
Sep 26, 2025

Brokers Set Expectations for PRLD Q3 Earnings - Defense World

Sep 26, 2025
pulisher
Sep 24, 2025

Prelude Therapeutics’ (PRLD) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Sep 24, 2025
pulisher
Sep 23, 2025

H.C. Wainwright reiterates Buy rating on Prelude Therapeutics stock with $5 target - Investing.com Canada

Sep 23, 2025
pulisher
Sep 23, 2025

Prelude Therapeutics (NASDAQ:PRLD) Receives Buy Rating from HC Wainwright - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

HC Wainwright & Co. Reiterates Buy Rating for PRLD, Price Target at $5.00 | PRLD Stock News - GuruFocus

Sep 23, 2025
pulisher
Sep 22, 2025

New PROTACs revealed in Prelude Therapeutics patent - BioWorld MedTech

Sep 22, 2025
pulisher
Sep 21, 2025

What momentum shifts mean for Prelude Therapeutics IncorporatedInsider Selling & Weekly Return Optimization Plans - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Will Prelude Therapeutics Incorporated benefit from macro trendsWeekly Trend Summary & Entry Point Confirmation Signals - newser.com

Sep 21, 2025
pulisher
Sep 20, 2025

Statistical indicators supporting Prelude Therapeutics Incorporated’s strength2025 Investor Takeaways & Consistent Growth Stock Picks - newser.com

Sep 20, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):